Esin, E.; Yildirim, H.C.; Oksuzoglu, B.; Markoc, F.; Guntekin, S.; Bilgetekin, I.; Yildiz, F.; Yukruk, F.; Demirci, U.; Cetin-Atalay, R.
Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study. J. Clin. Med. 2024, 13, 5328.
https://doi.org/10.3390/jcm13175328
AMA Style
Esin E, Yildirim HC, Oksuzoglu B, Markoc F, Guntekin S, Bilgetekin I, Yildiz F, Yukruk F, Demirci U, Cetin-Atalay R.
Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study. Journal of Clinical Medicine. 2024; 13(17):5328.
https://doi.org/10.3390/jcm13175328
Chicago/Turabian Style
Esin, Ece, Hasan Cagri Yildirim, Berna Oksuzoglu, Fatma Markoc, Sezen Guntekin, Irem Bilgetekin, Fatih Yildiz, Fisun Yukruk, Umut Demirci, and Rengul Cetin-Atalay.
2024. "Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study" Journal of Clinical Medicine 13, no. 17: 5328.
https://doi.org/10.3390/jcm13175328
APA Style
Esin, E., Yildirim, H. C., Oksuzoglu, B., Markoc, F., Guntekin, S., Bilgetekin, I., Yildiz, F., Yukruk, F., Demirci, U., & Cetin-Atalay, R.
(2024). Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study. Journal of Clinical Medicine, 13(17), 5328.
https://doi.org/10.3390/jcm13175328
